AVEAX
Price
$16.57
Change
+$0.30 (+1.84%)
Updated
Jun 6 closing price
Net Assets
64.06M
GAFFX
Price
$78.67
Change
+$0.76 (+0.98%)
Updated
Jun 6 closing price
Net Assets
304.87B
Interact to see
Advertisement

AVEAX vs GAFFX

Header iconAVEAX vs GAFFX Comparison
Open Charts AVEAX vs GAFFXBanner chart's image
Ave Maria Growth Focused
Price$16.57
Change+$0.30 (+1.84%)
VolumeN/A
Net Assets64.06M
American Funds Growth Fund of Amer F3
Price$78.67
Change+$0.76 (+0.98%)
VolumeN/A
Net Assets304.87B
AVEAX vs GAFFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AVEAX vs. GAFFX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVEAX is a Buy and GAFFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 305B vs. AVEAX (64.1M). GAFFX pays higher dividends than AVEAX: GAFFX (0.65) vs AVEAX (0.00). AVEAX was incepted earlier than GAFFX: AVEAX (5 years) vs GAFFX (8 years). AVEAX (1.11) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. AVEAX (22.00). AVEAX has a lower initial minimum investment than GAFFX: AVEAX (2500) vs GAFFX (1000000). AVEAX annual gain was more profitable for investors over the last year : 22.42 vs. GAFFX (9.74). AVEAX return over 5 years is better than : 54.36 vs. GAFFX (47.05).
AVEAXGAFFXAVEAX / GAFFX
Total Expense Ratio1.110.30370%
Annual Report Gross Expense Ratio1.110.30370%
Fund Existence5 years8 years-
Gain YTD6.3405.640112%
Front LoadN/AN/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets64.1M305B0%
Annual Yield % from dividends0.000.65-
Returns for 1 year22.429.74230%
Returns for 3 years34.3538.5689%
Returns for 5 years54.3647.05116%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KALV14.360.56
+4.09%
KalVista Pharmaceuticals
BRC70.000.45
+0.65%
Brady Corp
PKX47.710.03
+0.06%
POSCO Holdings
SLS1.61-0.02
-1.23%
SELLAS Life Sciences Group
CNET1.26-0.06
-4.56%
ZW Data Action Technologies Inc